BioStock: Chordate Medical avslutade 2021 med fokus på Saudiarabien

BioStock: Chordate Medical secures entrance to Chinese market

BioStock: Chordate Medicals vd uttalar sig om kritiken

BioStock: Successful outcome of Chordate Medical’s warrant

Analyst Group: Chordate Medical är i sitt bästa läge

Analyst Group: Kommentar på Chrodate Medicals Q3-rapport

BioStock: Chordate Medical’s migraine study enters final stage

BioStock: Chordate Medical’s CEO on US marketing plans

BioStock: Chordate Medical strengthens its Board of Directors

BioStock: Market report predicts strong growth for Chordate Medical’s technology